| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 34, 2670-2678, Copyright © 1981 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
R Riales and MJ Albrink
Chromium deficiency may cause insulin resistance, hyperinsulinemia, impaired glucose tolerance, and hyperlipidemia, recovered by chromium supplementation. The effect of chromium supplementation on serum lipids and glucose tolerance was tested in a double-blind 12-wk study of 23 healthy adult men aged 31 to 60 yr. Either 200 micrograms trivalent chromium in 5 ml water (Cr) or 5 ml plain water (W) was ingested daily 5 days each week. Half the subjects volunteered for glucose tolerance tests with insulin levels. At 12 wk high-density lipoprotein cholesterol increased in the Cr group from 35 to 39 mg/dl (p less than 0.05) but did not change in the water group (34 mg/dl). The largest increase in high-density lipoprotein cholesterol and decreases in insulin and glucose were found in those subjects having normal glucose levels together with elevated insulin levels at base-line. The data are thus consistent with the hypothesis that Cr supplementation raises high- density lipoprotein cholesterol and improves insulin sensitivity in those with evidence of insulin resistance but normal glucose tolerance.
This article has been cited by other articles:
|
|
 |
|
  E. M. Balk, A. Tatsioni, A. H. Lichtenstein, J. Lau, and A. G. Pittas Effect of Chromium Supplementation on Glucose Metabolism and Lipids: A systematic review of randomized controlled trials Diabetes Care, August 1, 2007; 30(8): 2154 - 2163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rink, S. Roy, S. Khanna, T. Rink, D. Bagchi, and C. K. Sen Transcriptome of the subcutaneous adipose tissue in response to oral supplementation of type 2 Leprdb obese diabetic mice with niacin-bound chromium Physiol Genomics, November 21, 2006; 27(3): 370 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. Cefalu and F. B. Hu Role of Chromium in Human Health and in Diabetes Diabetes Care, November 1, 2004; 27(11): 2741 - 2751. [Full Text] [PDF]
|
|
|
|
 |
|
 G. J Ryan, N. S Wanko, A. R Redman, and C. B Cook Chromium as Adjunctive Treatment for Type 2 Diabetes Ann. Pharmacother., June 1, 2003; 37(6): 876 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D Althuis, N. E Jordan, E. A Ludington, and J. T Wittes Glucose and insulin responses to dietary chromium supplements: a meta-analysis Am. J. Clinical Nutrition, July 1, 2002; 76(1): 148 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E Gunton, G. Hams, R. Hitchman, and A. McElduff Serum chromium does not predict glucose tolerance in late pregnancy Am. J. Clinical Nutrition, January 1, 2001; 73(1): 99 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Amato, A. J. Morales, and S. S. C. Yen Effects of Chromium Picolinate Supplementation on Insulin Sensitivity, Serum Lipids, and Body Composition in Healthy, Nonobese, Older Men and Women J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2000; 55(5): 260M - 263. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. A. Anderson Chromium, Glucose Intolerance and Diabetes J. Am. Coll. Nutr., December 1, 1998; 17(6): 548 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Baumgartner Invited Review: Trace Elements in Clinical Nutrition Nutr Clin Pract, December 1, 1993; 8(6): 251 - 263. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
